Yan Z., Zhou Y., Zhao Y., Zhou Z., Yang S., Wang Z.Impact of transradial coronary procedures on radial artery. Angiology. IN PRESS.
2.
Kim YO, Choi YJ, Kim JI, et al. The impact of intima-media thickness of radial artery on early failure of radiocephalic arteriovenous fistula in hemodialysis patients. J Korean Med Sci. 2006;21(2):284-289.
3.
Parmar J., Aslam M., Standfield N.Pre-operative radial artery diameter predicts early failure of arteriovenous fistula (AVF) for haemodialysis. Eur J Vasc Endovasc Surg . 2007;33(1):113-115.
4.
Elsharawy MAProspective evaluation of factors associated with early failure of arteriovenous fistulae in hemodialysis patients. Vascular. 2006;14(2):70-74.
5.
Liu BC, Li L., Gao M., Wang YL, Yu JRMicroinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis. Chin Med J (Engl). 2008;121(21):2157-2161.
6.
Wakeyama T., Ogawa H., Iida H., et al. Intima-media thickening of the radial artery after transradial intervention. An intravascular ultrasound study. J Am Coll Cardiol. 2003;41(7):1109-1114.
7.
Wang HY, Meng Y., Luo XJ, Wang QZ, Sun HS, Ruan YMPathological changes of radial artery used for coronary artery bypass grafting and its related risk factors for intimal hyperplasia. Zhongua Wai Ke Za Zhi. 2006; 44(2):83-86.
8.
Harley CR, Gandhi SK, Heien H., McDonough K., Nelson SPLipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother. 2008;9(5):669-676.
9.
McDonald KJ, Jardine AGThe use of fluvastatin in cardiovascular risk management. Expert Opin Pharmacother. 2008;9(8):1407-1414.
Athyros VG, Kakafika AI, Tziomalos K., Karagiannis A., Mikhailidis DPPleiotropic effects of statins-clinical evidence. Curr Pharm Des.2009;15(5):479-489.
12.
Paraskevas KI, Stathopoulos V., Mikhailidis DPPleiotropic effects of statins: implications for a wide range of diseases. Curr Vasc Pharmacol. 2008;6(4):237-239.
13.
Athyros VG, Kakafika AI, Tziomalos K., Papageorgiou AA, Karagiannis A.Statins for the prevention of first or recurrent stroke. Curr Vasc Pharmacol. 2008;6(2):124-133.
14.
Paraskevas KI, Athyros VG, Briana DD, Kakafika AI, Karagiannis A., Mikhailidis DPStatins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets. 2007; 8(8):942-951.
15.
Aydin U., Ugurculan M., Gungor F., et al. Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model. Angiology.2009 ;60(3):370-377.
16.
Westphal S. , Abletshauser C., Luley C.Fluvastatin treatment and withdrawal: effects on endothelial function. Angiology. 2008;59(5):613-618.
17.
Paraskevas KI, Hamilton G., Mikhailidis DPStatins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007 ;46(2):373-386.
18.
Bots ML, Palmer MK, Dogan S., et al, METEOR Study Group. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study . J Intern Med. 2009;265(6):698-707.
19.
Ricioni G., Bazzano LA, Bucciarelli T., Mancini B., di Ilio E., D’Orazio N.Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study. Expert Opin Pharmacother . 2008;9(14):2403-2408.
20.
Patti G., Pasceri V., Colonna G., et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol . 2007;49(12):1272-1278.
21.
Briguori C. , Visconti G., Focaccio A., et al. Novel Approaches for Preventing or Limiting Events (Naples) II Trial Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction. J Am Coll Cardiol. In press.
22.
Paraskevas KI, Mikhailidis DPC-reactive protein (CRP): more than just an innocent bystander? Curr Med Res Opin. 2008 ;24(1):75-78.
23.
Nakou ES, Liberopoulos EN, Milionis HJ, Elisaf MSThe role of C-reactive protein in atherosclerotic cardiovascular disease: an overview. Curr Vasc Pharmacol. 2008;6(4):258-270.
24.
Singh SK, Suresh MV, Voleti B., Agrawal A.The connection between C-reactive protein and atherosclerosis. Ann Med. 2008;40(2):110-120.
25.
Karha J., Bavry AA, Rajagopal V., Henderson MR, Ellis SG, Brener SJRelation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimuseluting stent. Am J Cardiol. 2006;98(5):616-618.
26.
Hong YJ, Jeong MH, Lim SY, et al. Relation of soft plaque and elevated preprocedural high-sensitivity Creactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting. Am J Cardiol. 2006 ;98(3):341-345.
27.
Palmerini T. , Marzocchi A., Marrozzini C., et al. Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis. Circulation. 2005;112(15):2332-2338.
28.
Fatourou EM , Paraskevas KI, Seifalian AM, Hamilton G., Mikhailidis DPThe role of established and emerging risk factors in peripheral vascular graft occlusion. Expert Opin Pharmacother. 2007;8(7):901-911.
29.
Owens CD, Ridker PM, Belkin M., et al. Elevated Creactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg. 2007;45(1):2-9.
30.
Abdellaoui A., Al-Khaffaf H.C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur J Vasc Endovasc Surg. 2007;34(1):18-22.
31.
Tsiara S., Elisaf M., Mikhailidis DPEarly vascular benefits of statin therapy. Curr Med Res Opin . 2003;19(6): 540-556.
32.
Ilerigelen B., Uresin Y., San M., et al. ; TULIPS Investigators. Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study). Curr Med Res Opin. 2007;23(5):1093-1102.
33.
Li JJ, Fang CH, Qian HY, Hu WLTime course of rapid C-reactive protein reduction by pravastatin in patients with stable angina. Angiology. 2006;57(1):1-7.
